Bavarian Explores Options to Boost Mpox Jab Supply by 50 Million
- Danish vaccine-maker will deliver 2 million doses by year-end
- So far, more than 250,000 doses have been shipped: Bavarian
A dose of the Bavarian Nordic A/S Jynneos monkeypox vaccine.
Photographer: Jill Connelly/BloombergThis article is for subscribers only.
Bavarian Nordic A/S, one of a few companies with an approved mpox vaccine, is increasing the number of jabs it could supply to deal with an outbreak in Africa.
Bavarian, which has faced criticism over the high cost of its vaccines, is prioritizing supplying the inoculations to Africa with a plan to defer some other 2024 orders to next year, according to a statement on Thursday.